P-139 A phase 2 multicohort study (LEAP-005) of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors: Pancreatic cancer cohort.

Saved in:
Bibliographic Details
Title: P-139 A phase 2 multicohort study (LEAP-005) of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors: Pancreatic cancer cohort.
Authors: Chung, H.1, Villanueva, L.2, Graham, D.3, Saada-Bouzid, E.4, Ghori, R.5, Kubiak, P.6, Gumuscu, B.5, Lerman, N.5, Gomez-Roca, C.7
Source: Annals of Oncology. 2021 Supplement 3, Vol. 32, pS146-S146. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2021.05.194